638 related articles for article (PubMed ID: 9686639)
1. Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection.
Wilson SE; Pedersen SL; Kunich JC; Wilkins VL; Mann DL; Mazzara GP; Tartaglia J; Celum CL; Sheppard HW
AIDS Res Hum Retroviruses; 1998 Jul; 14(11):925-37. PubMed ID: 9686639
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development.
Cao H; Kanki P; Sankalé JL; Dieng-Sarr A; Mazzara GP; Kalams SA; Korber B; Mboup S; Walker BD
J Virol; 1997 Nov; 71(11):8615-23. PubMed ID: 9343219
[TBL] [Abstract][Full Text] [Related]
3. Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients.
Durali D; Morvan J; Letourneur F; Schmitt D; Guegan N; Dalod M; Saragosti S; Sicard D; Levy JP; Gomard E
J Virol; 1998 May; 72(5):3547-53. PubMed ID: 9557634
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
[TBL] [Abstract][Full Text] [Related]
5. Equivalent recognition of HIV proteins, Env, Gag and Pol, by CD4+ and CD8+ cytotoxic T-lymphocytes.
Kundu SK; Merigan TC
AIDS; 1992 Jul; 6(7):643-9. PubMed ID: 1354446
[TBL] [Abstract][Full Text] [Related]
6. A vaccinia-gp160-based vaccine but not a gp160 protein vaccine elicits anti-gp160 cytotoxic T lymphocytes in some HIV-1 seronegative vaccinees.
Perales MA; Schwartz DH; Fabry JA; Lieberman J
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):27-35. PubMed ID: 7648281
[TBL] [Abstract][Full Text] [Related]
7. Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH.
Malm M; Rollman E; Ustav M; Hinkula J; Krohn K; Wahren B; Blazevic V
Viral Immunol; 2005; 18(4):678-88. PubMed ID: 16359234
[TBL] [Abstract][Full Text] [Related]
8. Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C.
Gómez CE; Nájera JL; Jiménez V; Bieler K; Wild J; Kostic L; Heidari S; Chen M; Frachette MJ; Pantaleo G; Wolf H; Liljeström P; Wagner R; Esteban M
Vaccine; 2007 Mar; 25(11):1969-92. PubMed ID: 17224219
[TBL] [Abstract][Full Text] [Related]
9. A novel method for detection and ex vivo expansion of HIV type 1-specific cytolytic T lymphocytes.
Lubaki MN; Egan MA; Siliciano RF; Weinhold KJ; Bollinger RC
AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1427-31. PubMed ID: 7888197
[TBL] [Abstract][Full Text] [Related]
10. Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection.
McAdam S; Kaleebu P; Krausa P; Goulder P; French N; Collin B; Blanchard T; Whitworth J; McMichael A; Gotch F
AIDS; 1998 Apr; 12(6):571-9. PubMed ID: 9583596
[TBL] [Abstract][Full Text] [Related]
11. Multiple subsets of HIV-specific cytotoxic T lymphocytes in humans and in mice.
Chenciner N; Michel F; Dadaglio G; Langlade-Demoyen P; Hoffenbach A; Leroux A; Garcia-Pons F; Rautmann G; Guy B; Guillon JM
Eur J Immunol; 1989 Sep; 19(9):1537-44. PubMed ID: 2676560
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the human env-specific cytotoxic T-lymphocyte (CTL) response in natural human immunodeficiency virus type 1 infection: low prevalence of broadly cross-reactive env-specific CTL.
Carmichael A; Jin X; Sissons P
J Virol; 1996 Dec; 70(12):8468-76. PubMed ID: 8970969
[TBL] [Abstract][Full Text] [Related]
13. Broad cross-clade T-cell responses to gag in individuals infected with human immunodeficiency virus type 1 non-B clades (A to G): importance of HLA anchor residue conservation.
Geels MJ; Dubey SA; Anderson K; Baan E; Bakker M; Pollakis G; Paxton WA; Shiver JW; Goudsmit J
J Virol; 2005 Sep; 79(17):11247-58. PubMed ID: 16103177
[TBL] [Abstract][Full Text] [Related]
14. Cross-clade-specific cytotoxic T lymphocytes in HIV-1-infected children.
Buseyne F; Chaix ML; Fleury B; Manigart O; Burgard M; Blanche S; Rouzioux C; Rivière Y
Virology; 1998 Oct; 250(2):316-24. PubMed ID: 9792842
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 env, nef, and gag-specific T-cell immunity in mice: conserved epitopes in nef p27 and gag p25 proteins.
Michel F; Hoffenbach A; Froussard P; Langlade-Demoyen P; Kaczorek M; Kieny MP; Plata F
AIDS Res Hum Retroviruses; 1992 Apr; 8(4):469-78. PubMed ID: 1376136
[TBL] [Abstract][Full Text] [Related]
16. Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers.
Ferrari G; Humphrey W; McElrath MJ; Excler JL; Duliege AM; Clements ML; Corey LC; Bolognesi DP; Weinhold KJ
Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1396-401. PubMed ID: 9037064
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
Carmichael A; Jin X; Sissons P; Borysiewicz L
J Exp Med; 1993 Feb; 177(2):249-56. PubMed ID: 8093890
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of HLA-A*3303-restricted, HIV type 1 Pol- and Gag-derived cytotoxic T cell epitopes.
Hossain MS; Tomiyama H; Inagawa T; Ida S; Oka S; Takiguchi M
AIDS Res Hum Retroviruses; 2003 Jun; 19(6):503-10. PubMed ID: 12882660
[TBL] [Abstract][Full Text] [Related]
19. Multiple CTL specificities against autologous HIV-1-infected BLCLs.
Ahearne PM; Morgan RA; Sebastian MW; Bolognesi DP; Weinhold KJ
Cell Immunol; 1995 Mar; 161(1):34-41. PubMed ID: 7867083
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation Group.
Corey L; McElrath MJ; Weinhold K; Matthews T; Stablein D; Graham B; Keefer M; Schwartz D; Gorse G
J Infect Dis; 1998 Feb; 177(2):301-9. PubMed ID: 9466515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
